Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Millions of Americans Use Cannabis to Help Them Sleep. It Could Be Doing The Opposite. : ScienceAlert (opens in a new tab)

Millions of Americans Use Cannabis to Help Them Sleep. It Could Be Doing The Opposite. · 2026-10-16

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 4 supported
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1

The story

Millions of Americans Use Cannabis to Help Them Sleep. It Could Be Doing The Opposite. : ScienceAlert

Millions of Americans Use Cannabis to Help Them Sleep. It Could Be Doing The Opposite. · 2026-10-16

The story’s checkable claims.

Read the original story (opens in a new tab)
2

NewsLink checks it

Mostly supported

Every claim we could check holds up. Four of five claims match the study. This overall rating is based only on the claims we could check. One claim the study doesn't address.

  • 4 supported
  • 1 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredAn estimated 22 million Americans use cannabis as a sleep aid, and nearly one in four say they are likely to try it for sleep.View evidenceHide evidence

As stated22 million Americans; almost one in four

Why this verdict

The abstract-level profile supports the general context that cannabis is commonly used or promoted as a sleep aid, but it does not provide or verify the specific prevalence figures of 22 million Americans or nearly one in four being likely to try cannabis for sleep.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 per cannabis-year (95% CI, 1.06–1.14)

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage (actigraphy-defined <85%) compared with former use and never use.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Claim 2 of 5SupportedA new study in JAMA Network Open found that cannabis use was associated with multiple objective measures of poorer sleep in observational data from the CARDIA study, while subjective sleep ratings did not show worse sleep among cannabis users.View evidenceHide evidence

As stated35 years of observational data; 1,266 participants; 891 objective sleep-data participants; 753 in both analyses

Why this verdict

The central claim matches the abstract-level profile: the CARDIA observational analysis used 35 years of follow-up, found cumulative and recent cannabis use associated with poorer objective sleep measures from 7-day wrist actigraphy, and found no association with self-reported PSQI sleep quality. The profile verifies the objective-analysis sample size of 891, but not all participant-count details stated in the story, such as 1,266 participants or 753 in both analyses.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 per cannabis-year (95% CI, 1.06–1.14)

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage (actigraphy-defined <85%) compared with former use and never use.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Claim 3 of 5SupportedThe evidence is starting to suggest that cannabis may have an overall detrimental effect on sleep quality, despite common beliefs that it helps sleep.View evidenceHide evidence

Why this verdict

The paper profile supports a hedged, associational interpretation that cannabis use may be linked to worse sleep: cumulative and recent use were associated with poorer objective actigraphy measures, while the background notes cannabis is commonly used or promoted as a sleep aid. This should be read as applying mainly to objective sleep quality, because the paper also found no association with subjective PSQI sleep quality.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 per cannabis-year (95% CI, 1.06–1.14)

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage (actigraphy-defined <85%) compared with former use and never use.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Claim 4 of 5SupportedGreater lifetime cannabis use was linked with lower sleep percentage, higher sleep fragmentation, and more prolonged waking during sleep; recent use was linked with longer sleep duration but also poorer objective sleep measures.View evidenceHide evidence

As stated10 percent higher odds of low sleep percentage per additional year of cannabis use; 4 percent higher odds of high sleep fragmentation; 21 percent higher odds of prolonged waking; 20 minutes extra sleep per night among recent users

Why this verdict

The lifetime-use findings are supported by the abstract-level profile: per additional cannabis-year, odds were higher for low sleep percentage, high sleep fragmentation, and prolonged WASO, with the stated ORs corresponding to 10%, 4%, and 21% higher odds. The recent-use findings are also supported in direction: recent past-30-day use was associated with low sleep percentage, high fragmentation, prolonged WASO, and greater odds of long sleep duration. The specific '20 minutes extra sleep per night' magnitude is not verified in the abstract-level profile.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 per cannabis-year (95% CI, 1.06–1.14)

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage (actigraphy-defined <85%) compared with former use and never use.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Claim 5 of 5SupportedThe researchers say the discrepancy may mean cannabis-related sleep disturbances go unrecognized, and they caution that the observational design cannot prove cannabis caused the sleep problems.View evidenceHide evidence

Why this verdict

The paper profile supports the discrepancy between objective and subjective sleep findings and the observational-design caveat that the study cannot establish causality. The exact interpretive wording that cannabis-related sleep disturbances 'may go unrecognized' is stronger than the profile's abstract-level summary, but it is consistent with the reported contrast between worse actigraphy measures and null PSQI findings.

1

Study evidence

Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 per cannabis-year (95% CI, 1.06–1.14)

“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
2

Study evidence

Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage (actigraphy-defined <85%) compared with former use and never use.

“recent cannabis use (defined as past 30-day use vs former use and never use)”
Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

7 things the story did carry across
  • The paper is an observational CARDIA cohort analysis, not an experiment or randomized trial.
  • Cumulative cannabis exposure was measured as cannabis-years over approximately 35 years and analyzed against Year-35 objective sleep outcomes.
  • Objective sleep was measured using 7-day wrist actigraphy at Year-35.
  • Greater cumulative cannabis use was associated with poorer objective sleep metrics: lower sleep percentage, higher fragmentation, and prolonged wake after sleep onset.
  • Recent past-30-day cannabis use was associated with poorer objective sleep measures and greater odds of long sleep duration.
  • Cannabis use was not associated with subjective sleep quality measured by PSQI.
  • Objective analyses were limited to the subset with actigraphy data, which may affect generalizability to all CARDIA participants.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataAssess whether long-term (cumulative) cannabis exposure from young adulthood to middle age is associated with objectively measured sleep outcomes in middle age.Prospective cohort observational analysis (CARDIA Year-35 ancillary; cross-sectional sleep measurement at Year-35)Expand

In plain English

In CARDIA participants assessed at Year-35, greater cumulative cannabis exposure (measured in cannabis-years across ~35 years) was associated with poorer objectively measured sleep on 7-day wrist actigraphy: each additional cannabis-year was linked to higher odds of low sleep percentage, greater sleep fragmentation, and prolonged wake after sleep onset. These associations were reported after multivariable adjustment; no association was observed with self-reported (PSQI) sleep quality.

Key findings

  • Each additional cannabis-year was associated with higher odds of low sleep percentage on 7-day actigraphy.OR 1.10 per cannabis-year (95% CI, 1.06–1.14)
  • Each additional cannabis-year was associated with higher odds of high sleep fragmentation on 7-day actigraphy.OR 1.04 per cannabis-year (95% CI, 1.01–1.08)
“This cohort study analyzed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including 35 years of follow-up through the year-35 examination (conducted in 2020 to 2022), and the CARDIA Year-35 Sleep Ancillary Study.”
What this piece can’t prove
  • Observational cohort analysis; abstract does not permit assessment of causality and potential residual confounding.
  • Objective sleep was measured at a single time point (7-day actigraphy at Year-35); temporal sequencing between cumulative exposure and contemporaneous sleep measurement is based on exposure aggregated over prior follow-up.
  • Abstract does not specify which covariates were included in the multivariable models.
2secondary dataAssess whether recent (past-30-day) cannabis use status is associated with objectively measured sleep outcomes in middle age.cohort-based observational analysisExpand

In plain English

In CARDIA Year-35 participants with 7-day wrist actigraphy, recent cannabis use (past-30-day) was associated with worse objective sleep metrics after multivariable adjustment: higher odds of low sleep percentage, high sleep fragmentation, prolonged wake after sleep onset, and greater odds of long sleep duration (vs optimal). Two example effect estimates reported vs never use were prolonged WASO (OR 3.23, 95% CI 1.44–7.27) and long sleep duration (OR 4.60, 95% CI 1.81–11.70). No association was observed between cannabis use and subjective sleep quality (PSQI) in the abstract.

Key findings

  • Recent (past-30-day) cannabis use was associated with higher odds of low sleep percentage (actigraphy-defined <85%) compared with former use and never use.
  • Recent (past-30-day) cannabis use was associated with higher odds of high sleep fragmentation (highest quartile) compared with former use and never use.
“recent cannabis use (defined as past 30-day use vs former use and never use)”
What this piece can’t prove
  • Observational cohort analysis—associations may be subject to confounding and do not establish causality (limitation of study design noted by nature of analysis).
  • Objective analyses limited to the subset with actigraphy data (n=891), which may affect generalizability to the full CARDIA cohort.
  • Some reported associations are provided in aggregate (recent vs former/never) and the abstract gives numeric ORs for selected contrasts (vs never use) but not for all outcomes or all pairwise contrasts.

1 further detail could not be confirmed from the summary.

3secondary dataAssess whether cumulative and/or recent cannabis use is associated with subjective (self-reported) sleep quality in middle age.cohort observational analysisExpand

In plain English

In CARDIA participants at Year-35, cumulative cannabis exposure (cannabis‑years) and recent past-30-day cannabis use were analyzed in relation to self-reported sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI). After multivariable adjustment, the study reports no association between cannabis use (both cumulative and recent) and subjective sleep quality (PSQI score or prevalence of poor sleep defined as PSQI >5).

Key findings

  • No association was observed between cumulative or recent cannabis use and subjective sleep quality measured by the PSQI (continuous score or PSQI >5) after multivariable adjustment.
“subjective sleep was assessed with the Pittsburgh Sleep Quality Index (PSQI)”
What this piece can’t prove
  • PSQI is a self-report instrument and may not capture the same aspects of sleep as objective measures.
  • Potential residual confounding and measurement error in exposure and outcome ascertainment inherent to observational data.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 16 candidate papers

Candidate

Analysis of nighttime sleep fragmentation of actigraphy rest/activity patterns in healthy, young sedentary nappers

Sleep Medicine · 2019 · Crossref

Source (opens in a new tab)
Candidate

Supplemental Material for Sleep Fragmentation, 24-hr Rest–Activity Patterns, and Cognitive Function in Premanifest Huntington’s Disease: An Actigraphy Study

Neuropsychology · 2025 · Crossref

Source (opens in a new tab)

And 10 more candidates considered.